Assessment of correlation among each measurement of liver fibrosis based on pathological diagnosis in resected specimen in chronic hepatitis and cirhhosis patients.

Assessment of correlation among each measurement of liver fibrosis based on pathological diagnosis in resected specimen in chronic hepatitis and cirhhosis patients. - Liverfibrosis Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008658

Enrollment

150

Registered

2012-08-09

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease to be resected

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo hepatectomy or liver transplantation at our institution, provide a written informed consent at least 20 years or older.

Exclusion criteria

Exclusion criteria: Contraindication of this procedure. Patient with insufficient specimen Patients who are judged to have high risk in undergoing this trial.

Design outcomes

Primary

Measure	Time frame
Correlation evaluation between each liver fibrosis measurement and quantified histological finding.	—

Secondary

Measure	Time frame
To evaluate the best combination of liver fibrosis measurement. Correlation evaluation with intraoperative bleeding and RTE,ARFI Correlation evaluation with incidence of postoperative complication and RTE,ARFI	—

Countries

Japan

Contacts

Public ContactHiroko Okinaga

The University of Tokyo Hospital Hepato-Billiary-Pancreatic Surgery Division,Artificial Organ and Transplantation Division

YOSHINOH-SUR@h.u-tokyo.ac.jp03-3815-5411

Outcome results